Symbiotix Biotherapies, Inc.

Biotechnology company · Brookline, Massachusetts, United States

Symbiotix Biotherapies, Inc. is a biotechnology company headquartered in Brookline, Massachusetts, United States. It has received 3 US government small-business research awards (SBIR/STTR) from health agencies, $4.6 million in total, most recently in 2016.

Profile compiled from public records. Is this your company? Request a correction or update

Symbiotix Biotherapies at a glance

Typebiotechnology company

HeadquartersBrookline, Massachusetts, United States

Employees (self-reported, 2016)2

What does Symbiotix Biotherapies do?

US government research funding

3 SBIR/STTR small-business research awards from US health agencies, $4.6 million in total (2014 to 2016). NIH funding came from the National Institute of Diabetes and Digestive and Kidney Diseases.

Frequently asked questions about Symbiotix Biotherapies

Where is Symbiotix Biotherapies headquartered?

Symbiotix Biotherapies, Inc. is headquartered in Brookline, Massachusetts, United States.

What does Symbiotix Biotherapies do?

Symbiotix Biotherapies, Inc. is a biotechnology company.

Similar companies

Crimson BioPharm Inc.Brookline, Massachusetts, United States
Day Zero Diagnostics, Inc.Brookline, Massachusetts, United States
Hypnalgesics, LLCBrookline, Massachusetts, United States
Navigation Sciences, Inc.Brookline, Massachusetts, United States
Hydroglyde Coatings, LLCBrookline, Massachusetts, United States
Rgenta Therapeutics LLCBrookline, Massachusetts, United States
Adecto Pharmaceuticals, Inc.Brookline, Massachusetts, United States
Neurotargeting SystemsBrookline, Massachusetts, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences